Refeyn launches KaritroMP for rapid and reproducible characterization of large viral vectors

Refeyn, a leader in mass photometry technology, announces the launch of its macro mass photometry platform, KaritroMP.

How a combination of covid lawsuits and media coverage keeps misinformation churning

Public health has had its day in court lately. And another day. And another day.

July 14, 2023

The MSOs Are Pulling Back

You’re reading this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. The newsletter includes unique insight

April 26, 2024

Specification of the full-year forecast – Biotech Investments

Medios AG / Key word(s): Annual Results Medios AG: Specification of the full-year forecast 12-Dec-2024 / 13:27 CET/CEST Disclosure of an inside information acc. to

December 13, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.